CARTERRA- LSA PLATFORM
Carterra- LSA platform is a versatile, fully integrated, high throughput monoclonal antibody (mAb) characterization platform that combines patented flow printing microfluidics with high throughput surface plasmon resonance (SPR) detection to deliver up to 100x the data in 10% of the time and with 1% of the sample requirements and consumable costs of other systems.
CARTERRA- LSA PLATFORM
Industry:
Biotechnology Information Services
Founded:
2018-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.carterra-bio.com
Status:
Active
Official Site Inspections
http://www.carterra-bio.com
- Host name: 229.18.229.35.bc.googleusercontent.com
- IP address: 35.229.18.229
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Carterra- LSA platform"
Management Team - Carterra
Josh Eckman Chief Executive Officer. Since founding Carterra (formerly Wasatch Microfluidics) in 2005, Mr. Eckman has been instrumental in securing funding, attracting key employees and advisors, developing strategic partnerships, โฆSee details»
Carterra: High Throughput Antibody Screening & Characterization
During our testing of the Carterra Ultra, we were able to screen a vast array of molecular interactions in parallel. Weโre excited about this revolutionary new SPR platform as it will โฆSee details»
Carterra - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 844 642 7635 Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition โฆSee details»
Carterra Company Profile 2024: Valuation, Funding
Carterra General Information Description. Operator of a biosensor platform intended to accelerate the discovery of novel therapeutic candidates. The company's monoclonal antibody (mAb) characterization platform combines โฆSee details»
Carterra Company Profile - Office Locations, Competitors ... - Craft
Carterra has 5 employees across 4 locations and $30 m in total funding,. See insights on Carterra including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
Genovac Acquires the Carterra LSA® Instrument to ... - Business โฆ
Apr 20, 2022 For additional information, please visit www.carterra-bio.com. About Genovac Genovac is a contract research and manufacturing organization offering the worldโs most โฆSee details»
La Jolla Institute for Immunology Acquires the Carterra โฆ
Aug 1, 2022 For additional information, please visit www.carterra-bio.com. About La Jolla Institute. ... Since its founding in 1988 as an independent, nonprofit research organization, ...See details»
Genovac Acquires the Carterra LSA
Apr 20, 2022 Genovac becomes Carterraโs 100th LSA placement throughout the world. Fargo, North Dakota and Salt Lake City, Utah โ April 20, 2022โ Genovac, a leading contract โฆSee details»
Carterra - Drug Target Review
The Carterra LSA is a fully integrated antibody characterisation platform that uses Array SPR to analyse up to 384 binding interactions simultaneously. ... www.carterra-bio.com. 825 N. 300 W. Ste. C309 Salt Lake City, UT 84103 โฆSee details»
PRESS RELEASE: Icosagen Acquires the Carterra LSA โฆ
For additional information, please visit www.carterra-bio.com. About Icosagen Group Icosagen Group is a biotechnology company that was founded in 1999 and has since grown to employ over 170 CRDMO (Contract Research, โฆSee details»
Genovac Acquires the Carterra LSA Instrument to Enable State-of โฆ
For more information, visit www.carterra-bio.com. Genovac is a contract research and manufacturing organization offering the worldโs most advanced antibody discovery solutions. โฆSee details»
Institute for Protein Innovation Buys Carterra Next-Generation โฆ
Apr 4, 2018 www.carterra-bio.com About Institute for Protein Innovation (IPI). IPI is a non-profit research organization whose mission is to foster innovation in protein research, train the next โฆSee details»
Icosagen Acquires the Carterra LSA Instrument to Significantly โฆ
Apr 11, 2023 For additional information, please visit www.carterra-bio.com. About Icosagen Group Icosagen Group is a biotechnology company that was founded in 1999 and has since โฆSee details»
Icosagen Acquires the Carterra LSA Instrument to Significantly โฆ
Mar 20, 2023 Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, PerkinElmer. For additional information, please visit www.carterra-bio.com . About โฆSee details»
Bio-Techne And Carterra Initiate A Clinical Research Collaboration โฆ
Sep 8, 2021 Bio-Techne and Carterra are aligned in this mission." The Carterra LSA will be used to generate high-definition insights with over 120 data points from patient serum samples, โฆSee details»
Carterra unveils its most sensitive biosensor platform; Carterra โฆ
Sep 4, 2024 Carterra's high throughput LSA, LSA XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented โฆSee details»
Careers - Carterra
Carterra is an equal opportunity employer offering competitive salaries, comprehensive health benefits and equity packages. 825 N. 300 W. Ste. C309 Salt Lake City, UT 84103. Ph: (844) โฆSee details»
Support - Carterra
Carterra strives to provide you the best application and instrument platform support in the industry. Our customers rank our support team 4.7 out of 5 stars. ... Or contact our support โฆSee details»
Product Overview - Carterra
Carterra products are the standard for modern drug discovery processes leveraging AI/ML. The scale of data generated enables a robust design and test strategy to build confidence in โฆSee details»